Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

  1. Mastellos, D.C.
  2. Blom, A.M.
  3. Connolly, E.S.
  4. Daha, M.R.
  5. Geisbrecht, B.V.
  6. Ghebrehiwet, B.
  7. Gros, P.
  8. Hajishengallis, G.
  9. Holers, V.M.
  10. Huber-Lang, M.
  11. Kinoshita, T.
  12. Mollnes, T.E.
  13. Montgomery, R.A.
  14. Morgan, B.P.
  15. Nilsson, B.
  16. Pio, R.
  17. Ricklin, D.
  18. Risitano, A.M.
  19. Taylor, R.P.
  20. Mantovani, A.
  21. Ioannidis, J.P.A.
  22. Lambris, J.D.
Aldizkaria:
Nature Immunology

ISSN: 1529-2916,  1529-2908

Argitalpen urtea: 2019

Alea: 20

Zenbakia: 11

Orrialdeak: 1556

Mota: Hutsen zuzenketa

DOI: 10.1038/S41590-019-0531-X GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus